SCHEMBL7495137

SCHEMBL7495137

CC(=O)N(Cc1nc(-c2ccccc2)c(-c2ccccc2)o1)C1CCc2c(OCC(=O)O)cccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 2/20 0.46
NR4A2 P43354 11/20 0.46
PPARD Q03181 3/20 0.43
NR4A1 P22736 3/20 0.41
NR4A3 Q92570 3/20 0.41
RXRA P19793 5/20 0.40
RXRB P28702 4/20 0.40
RXRG P48443 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ABCC4 O15439 1/20 0.40
C5 P01031 1/20 0.40
LMNA P02545 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40
CHRM1 P11229 1/20 0.40
DRD2 P14416 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
TBXA2R P21731 1/20 0.40
PTGS1 P23219 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8589864 0.92 PTGIR (0.45) PTGIRNR4A2PPARDNR4A1NR4A3
SCHEMBL7486860 0.91 PTGIR (0.43) PTGIRNR4A2PPARDNR4A1NR4A3
SCHEMBL7493526 0.91 NR4A2 (0.45) PTGIRNR4A2NR4A1NR4A3RXRA
SCHEMBL7496987 0.90 NR4A2 (0.49) PTGIRNR4A2PPARDNR4A1NR4A3
SCHEMBL7497865 0.88 PTGIR (0.46) PTGIRNR4A2PPARDNR4A1NR4A3
SCHEMBL7498928 0.87 PTGIR (0.45) PTGIRNR4A2PPARDNR4A1NR4A3
SCHEMBL7488291 0.86 PTGIR (0.46) PTGIRNR4A2PPARDNR4A1NR4A3
SCHEMBL7489527 0.85 PTGIR (0.51) PTGIRNR4A2PPARDNR4A1NR4A3
SCHEMBL8591135 0.83 PTGIR (0.42) PTGIRNR4A2PPARDNR4A1NR4A3
SCHEMBL7485192 0.82 PTGIR (0.48) PTGIRNR4A2PPARDKDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed